Avis Budget Group, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Brian J. Choi
- Full Time Employees
- 25,000
- Sector
- Industrials
- Industry
- Rental & Leasing Services
- Address
- 379 Interpace Parkway Parsippany NJ United States of America 07054
- IPO Date
- Sep 14, 1983
- CIK
- 0000723612
- Website
- avisbudgetgroup.com
- Similar Companies
- Business
- Avis Budget Group, Inc. operates as a global provider of mobility solutions through three leading brands: Avis, Budget, and Zipcar. The company specializes in car rental services including standard car and truck rentals, corporate and leisure vehicle rentals, and on-demand car-sharing services primarily through its Zipcar brand. Its product offerings include a diverse fleet ranging from economy to premium and luxury vehicles, cargo vans, moving trucks (under Budget Truck), and specialty rentals such as child safety seats and GPS navigation systems. Avis Budget Group caters to a broad customer base including leisure and business travelers, event planners, and governments, operating extensively across North America, Europe, and select international markets. Founded in 1946 and headquartered in Parsippany, New Jersey, the company has developed value-added services such as Avis First, a premium car rental product introduced in 2025, which provides frictionless curbside pick-up and drop-off with dedicated concierge services. Recent strategic developments within the last two years include the launch of Avis First, reflecting a shift towards a premium service model intended to enhance customer experience and operational excellence. Avis Budget Group has focused on fleet modernization with a disciplined approach to vehicle acquisition, including managing the impact of vehicle recalls on fleet utilization and depreciation. The company emphasizes technological innovation through partnerships, notably with Waymo, to advance autonomous vehicle fleet management. Additionally, it has undertaken focused cost discipline measures to sustain profitability amid a mixed demand environment, especially addressing challenges in commercial and government segments. Future outlook anticipates growth aligned with key global events in 2026, including the World Cup and America's 250th anniversary, aimed at driving increased demand and revenue. Avis Budget Group maintains a significant presence through its integrated rental, truck, and car-sharing platforms, leveraging an extensive, connected vehicle fleet. It reinforces its market position through ongoing customer experience enhancements, digital innovation including artificial intelligence for service personalization, and strategic operational adjustments to meet evolving mobility needs worldwide. Recent executive management realignment in 2024 further reflects the company’s focus on financial discipline and growth execution. In summary, Avis Budget Group combines comprehensive vehicle rental solutions, premium service offerings, robust fleet management, and innovative technology partnerships to serve a diversified global customer base in the mobility industry. Its latest initiatives underscore a strategic pivot to upscale customer experience while maintaining operational efficiency and preparing for key market demand drivers in the near future.
Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026
Avis Budget Group to Announce Second Quarter 2026 Results on July 28, 2026
Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches
Fate Therapeutics to Present Preliminary Clinical Data of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Sclerosis at the ISSCR 2026 Annual Meeting
Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date
Kyverna Therapeutics: The Autoimmune CAR T Beachhead Is Bigger Than SPS
Allogene Therapeutics: A High-Upside Bet On The Next Wave Of CAR-T Innovation
Strong Car Rental Demand Aids Avis Budget Group Amid Low Liquidity
Powder Keg Stocks: 10 Most‑Shorted Names Primed For A Monster Squeeze
Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium
Avis Wins $650 Million From Hedge Fund That Bet Big on Its Stock
Reasons Why You Should Retain Avis Budget Stock in Your Portfolio
Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Lyell Immunopharma: Undervalued Ahead Of A Major CAR-T Inflection
These 10 Stocks Are Getting Crushed By Short Sellers Right Now
Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases
Caribou Biosciences Says CRISPR CAR-T Is Pivotal-Ready, CB-011 Data Nears
Xenetic Biosciences, Inc. Announces That Its Collaboration Partner Received Approval From the Israeli Ministry of Health to Conduct Exploratory, Investigator Initiated Study of DNase I In Combination With Anti-CD19 CAR T Cells in Large B-Cell Lymphoma
Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL)